-
Orange Grove Bio Sets Sights on Rapidly Emerging Middle East Biotech Ecosystem through New Academic Collaboration with Weizmann Institute of Science
31 Jan 2024 12:00 GMT
… the rapidly expanding biotechnology entrepreneurial ecosystem in … development stage to clinical trials. About Orange Grove … medical centers, and entrepreneurs to develop innovative treatments for … trademark of Teva Pharmaceutical Industries LTD; Rebif® is a …
-
Rebif dosage
23 Jan 2024 14:23 GMT
… the Food and Drug Administration (FDA) to treat:
Rebif is a biologic … Rebif, your doctor will discuss your treatment plan with you.
The Rebif dosage your doctor … your doctor or another healthcare professional before taking any medication. The drug information …
-
What Do We Know about Medication Adherence Interventions in Inflammatory Bowel Disease, Multiple Sclerosis and Rheumatoid Arthritis? A Scoping Review of Randomised Controlled Trials
12 Dec 2023 23:58 GMT
… and efficacy randomised controlled trials (RCTs) in … concentration of medication or electronic drug monitoring,45 … ), through the NIHR Doctoral Fellowship programme (NIHR302646 to … attitudes to medicines and adherence to maintenance treatment in inflammatory …
-
October - December 2022 | Potential Signals of Serious Risks/New Safety Information Identified by the FDA Adverse Event Reporting System (FAERS)
06 Apr 2023 13:13 GMT
… -1a)
Rebif (interferon beta-1a)
Pulmonary hypertension
FDA is evaluating … anti-inflammatory drugs (NSAIDs)
Generalised bullous fixed drug eruption
FDA is … osteoporosis medicine Prolia (denosumab)
Semglee (insulin glargine)
Device malfunction
FDA …
-
April - June 2023 | Potential Signals of Serious Risks/New Safety Information Identified by the FDA Adverse Event Reporting System (FAERS)
10 Feb 2023 08:45 GMT
… beta-1a)
Rebif (interferon beta-1a)
Myocardial infarction
FDA decided no … that contribute to wrong drug errors
FDA is evaluating the need … may contribute to wrong drug errors
FDA is evaluating the … that contribute to wrong drug errors
FDA is evaluating the need …
-
Beta Interferon Drugs Sales Expected to Reach USD 4.8 Billion by 2033 as Rising in Cases of Chronic Disorders: Fact.MR Analysis
27 Feb 2023 11:00 GMT
… Amoytop Biotech Co
Changchun Institute of Biological Products
Hainan Unipul Pharmaceutical
Kawin … beta interferon drugs. Rebif® (interferon beta-1a) is an effective medication for relapse … advanced therapeutics used for the treatment of several diseases like …
-
eureKARE co-founds EonBio to revolutionize drug discovery with pioneering cell-free technology on a chip
22 Feb 2023 09:03 GMT
… address high unmet medical needs by reconstructing … Georges Rawadi, Chief of Biotech Studio Development at eureKARE, … transform the way pharmaceutical companies approach drug discovery, vaccine … therapies, such as Copaxone, Rebif, Tookad®, Erbitux®, Vectibix®, …
-
$130,000 a year for medicine is outrageous. But I blame the government, not drugmakers.
21 Feb 2023 12:38 GMT
… .
And one of those medications, Rebif, is over three times … not just Medicare recipients, is the solution to lower pharmaceutical prices. … FDA's slow and complex approval process for generic drugs … More:Bureaucrats are telling your doctor how to treat pain. …
-
Swiss Philanthropist Gifts $75 Million to Harvard Medical School
13 Feb 2023 23:13 GMT
… last unnamed building in the Medical School – the Bertarelli Building. Bertarelli … of the biotech company Serono, maker of the multiple sclerosis drug Rebif. Currently … pipeline for therapeutic development, from medicine discovery to regulatory approval.
“I …
-
Drugmakers Raise Prices on Nearly 1,000 Medicines
02 Feb 2023 12:45 GMT
Pharmaceutical companies raised list prices of … federal law aimed at lowering medicine costs.
Pfizer Inc., Novartis AG … to 46brooklyn Research, a nonprofit drug-pricing analytics group. In recent … , including the multiple-sclerosis therapy Rebif.